Insider Transactions in Q4 2020 at Paratek Pharmaceuticals, Inc. (PRTK)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 14
2020
|
Michael Bigham Exec. Chairman of the Board |
SELL
Open market or private sale
|
Direct |
26,063
-4.55%
|
$156,378
$6.71 P/Share
|
|
Dec 14
2020
|
Randall B. Brenner Chief Development & Regulatory |
SELL
Open market or private sale
|
Direct |
8,760
-6.37%
|
$52,560
$6.71 P/Share
|
|
Dec 14
2020
|
William M. Haskel CLO, General Counsel & Sec. |
SELL
Open market or private sale
|
Direct |
6,842
-3.26%
|
$41,052
$6.71 P/Share
|
|
Dec 14
2020
|
Adam Woodrow President & Chief Commercial |
SELL
Open market or private sale
|
Direct |
12,855
-4.52%
|
$77,130
$6.71 P/Share
|
|
Dec 14
2020
|
Evan Loh CEO |
SELL
Open market or private sale
|
Direct |
26,415
-4.21%
|
$158,490
$6.71 P/Share
|
|
Dec 11
2020
|
Michael Bigham Exec. Chairman of the Board |
SELL
Open market or private sale
|
Direct |
18,337
-3.1%
|
$110,022
$6.95 P/Share
|
|
Dec 11
2020
|
Randall B. Brenner Chief Development & Regulatory |
SELL
Open market or private sale
|
Direct |
6,164
-4.29%
|
$36,984
$6.95 P/Share
|
|
Dec 11
2020
|
William M. Haskel CLO, General Counsel & Sec. |
SELL
Open market or private sale
|
Direct |
4,814
-2.24%
|
$28,884
$6.95 P/Share
|
|
Dec 11
2020
|
Adam Woodrow President & Chief Commercial |
SELL
Open market or private sale
|
Direct |
9,045
-3.09%
|
$54,270
$6.95 P/Share
|
|
Dec 11
2020
|
Evan Loh CEO |
SELL
Open market or private sale
|
Direct |
18,585
-2.88%
|
$111,510
$6.95 P/Share
|
|
Nov 13
2020
|
Adam Woodrow President & Chief Commercial |
SELL
Open market or private sale
|
Direct |
15,000
-4.87%
|
$75,000
$5.93 P/Share
|
|
Nov 13
2020
|
William M. Haskel CLO, General Counsel & Sec. |
SELL
Open market or private sale
|
Direct |
6,892
-3.11%
|
$34,460
$5.93 P/Share
|
|
Nov 13
2020
|
Michael Bigham Exec. Chairman of the Board |
SELL
Open market or private sale
|
Direct |
26,250
-4.25%
|
$131,250
$5.93 P/Share
|
|
Nov 13
2020
|
Randall B. Brenner Chief Development & Regulatory |
SELL
Open market or private sale
|
Direct |
8,357
-5.5%
|
$41,785
$5.93 P/Share
|
|
Nov 13
2020
|
Evan Loh CEO |
SELL
Open market or private sale
|
Direct |
20,928
-3.14%
|
$104,640
$5.93 P/Share
|
|
Nov 12
2020
|
Adam Woodrow President & Chief Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+10.85%
|
-
|
|
Nov 12
2020
|
William M. Haskel CLO, General Counsel & Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
23,125
+9.44%
|
-
|
|
Nov 12
2020
|
Michael Bigham Exec. Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+10.84%
|
-
|
|
Nov 12
2020
|
Randall B. Brenner Chief Development & Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
21,250
+12.26%
|
-
|
|
Nov 12
2020
|
Evan Loh CEO |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+10.11%
|
-
|
|
Oct 29
2020
|
Evan Loh CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
39,479
+6.26%
|
$157,916
$4.3 P/Share
|